MedTrace Logo

Hemoglobin Easy Measurement With Optical Artificial Intelligence

NCT04573244 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 823

Last updated 2024-08-23

No results posted yet for this study

Summary

Blood hemoglobin levels are an extremely important measure for a large swath of medical procedures as they reflect the oxygen-carrying capacity of human blood. The gold standard measure for blood hemoglobin levels involve a venous blood draw followed by a laboratory-based complete blood count (CBC), a process which is both painful and time consuming. To date, various methodologies have been tested to either expediate the process or provide a non-invasive alternative. There remains a need to provide a quick, pain-free/non-invasive and accurate modality to measure blood hemoglobin levels. The objective of this study is to determine whether computer vision technologies can be applied to fingernail images captured via a smartphone camera to quantify blood hemoglobin levels.

Conditions

  • Hemoglobin; Deficiency

Sponsors & Collaborators

  • MYOR Ltd.

    lead INDUSTRY

Principal Investigators

  • Gilad Moshe Chayen, MD · Emek Medical Center

Eligibility

Min Age
6 Months
Max Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-12-02
Primary Completion
2023-08-31
Completion
2023-08-31

Countries

  • Israel

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04573244 on ClinicalTrials.gov